Search results
Results from the WOW.Com Content Network
YM BioSciences Inc. was a Canadian drug development company primarily focused on advancing CYT-387, an orally administered inhibitor of both the JAK1 and JAK2 kinases, which have been implicated in a number of hematological and immune cell disorders including myeloproliferative neoplasms and inflammatory diseases as well as certain cancers. YM ...
Giddy from GileadIf you owned shares in YM Biosciences (ASE: YMI) , you're. Santa came early for some investors. Several health-care stocks took a sleigh ride up the charts. Here are three of the ...
Incyte (NAS: INCY) and Novartis' (NYS: NVS) ruxolitinib has a clear lead over YM BioSciences' (ASE: YMI) CYT387, but that hasn't stopped investors from making a bet on the YM BioSciences ...
Gilead Sciences Completes Acquisition of YM BioSciences FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (NAS: GILD) today announced that it has completed its acquisition of YM ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
For premium support please call: 800-290-4726 more ways to reach us
For instance, YM Biosciences (ASE: YMI) On a day when the Dow Jones Industrial Average (INDEX: ^DJI) surged 291 points as positive consumer-spending data from Black Friday rolled in, significantly ...